MOU
Seoul Center, LKB-Pyeongsan HB Sign Bio Deep-Tech MOU
Dong-A Ilbo |
Updated 2026.02.12
The Seoul Startup Hub Foundation Center for Creative Economy & Innovation (CEO Lee Young-geun) and LKB Pyeongsan Health Bio Center (Chairmen Lee Woo-ryong and Kim Soo-dong, hereinafter LKB Pyeongsan HB) signed a memorandum of understanding (MOU) on the 10th at the Seoul Center for Creative Economy & Innovation to jointly identify and foster innovative startups in the bio-healthcare and deep tech sectors.
This agreement was prepared to combine the resources and capabilities of the two institutions to accelerate investment attraction and global expansion for promising startups and to contribute to innovative growth in the domestic startup ecosystem. In particular, Ajou University Advanced Medical-Bio Research Institute, the Convergence Medical Products Support Center, and Kaiser Startup Academy, among other specialized institutions in the bio and medical fields, joined as co-signatories, forming a robust support network that spans the public, private, and academic sectors.
Under the agreement, the two organizations plan to pursue comprehensive cooperation in areas including: ▲ discovering outstanding startups and jointly fostering them (such as regulatory approval consulting) ▲ joint investment and fund linkage (Seed/Pre-A investment and establishment of Co-GP funds) ▲ joint research and technology commercialization (transfer of public technologies and support for clinical trials) ▲ support for global expansion by leveraging overseas VC/CRO networks ▲ hosting open innovation demo days and technology exchange events.
Specifically, the Seoul Center for Creative Economy & Innovation will provide public startup incubation platforms and investment networks such as TIPS linkage, while LKB Pyeongsan HB will be responsible for specialized technology commercialization consulting, including bio-healthcare technology evaluation, clinical and regulatory advisory services, raw material development, and quality control.
Lee Young-geun, CEO of the Seoul Center for Creative Economy & Innovation, stated, “The combination of Seoul Startup Hub’s public investment platform and LKB Pyeongsan HB’s specialized technology infrastructure will provide a practical growth springboard for bio startups,” adding, “In particular, as a startup hub institution, we will work with LKB Pyeongsan HB to identify growth opportunities for bio and deep tech startups.”
Kim Soo-dong, Chairman of LKB Pyeongsan Health Bio Center, said, “The vitalization of the startup ecosystem in the Republic of Korea will become even more important going forward,” and emphasized, “We will faithfully serve as a bridge in discovering practical bio and deep tech innovation success models.”
IT Donga reporter Cha Joo-gyeong (racingcar@itdonga.com)
This agreement was prepared to combine the resources and capabilities of the two institutions to accelerate investment attraction and global expansion for promising startups and to contribute to innovative growth in the domestic startup ecosystem. In particular, Ajou University Advanced Medical-Bio Research Institute, the Convergence Medical Products Support Center, and Kaiser Startup Academy, among other specialized institutions in the bio and medical fields, joined as co-signatories, forming a robust support network that spans the public, private, and academic sectors.
(From left) Lee Young-geun, CEO of the Seoul Center for Creative Economy & Innovation, Kim Soo-dong, Chairman of LKB Pyeongsan Health Bio Center, and Lee Woo-ryong, Chairman of LKB Pyeongsan Health Bio Center, sign a business agreement to support tech startups in the bio, healthcare, and deep tech fields. / Source = Seoul Center for Creative Economy & Innovation
Under the agreement, the two organizations plan to pursue comprehensive cooperation in areas including: ▲ discovering outstanding startups and jointly fostering them (such as regulatory approval consulting) ▲ joint investment and fund linkage (Seed/Pre-A investment and establishment of Co-GP funds) ▲ joint research and technology commercialization (transfer of public technologies and support for clinical trials) ▲ support for global expansion by leveraging overseas VC/CRO networks ▲ hosting open innovation demo days and technology exchange events.
Specifically, the Seoul Center for Creative Economy & Innovation will provide public startup incubation platforms and investment networks such as TIPS linkage, while LKB Pyeongsan HB will be responsible for specialized technology commercialization consulting, including bio-healthcare technology evaluation, clinical and regulatory advisory services, raw material development, and quality control.
Lee Young-geun, CEO of the Seoul Center for Creative Economy & Innovation, stated, “The combination of Seoul Startup Hub’s public investment platform and LKB Pyeongsan HB’s specialized technology infrastructure will provide a practical growth springboard for bio startups,” adding, “In particular, as a startup hub institution, we will work with LKB Pyeongsan HB to identify growth opportunities for bio and deep tech startups.”
Kim Soo-dong, Chairman of LKB Pyeongsan Health Bio Center, said, “The vitalization of the startup ecosystem in the Republic of Korea will become even more important going forward,” and emphasized, “We will faithfully serve as a bridge in discovering practical bio and deep tech innovation success models.”
IT Donga reporter Cha Joo-gyeong (racingcar@itdonga.com)
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
Popular News
